Product Information
- (2-{[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl}-1H-indol-1-yl)acetic acid
- 1H-Indole-1-acetic acid, 2-[[[4-(2-chlorophenyl)-2-thiazolyl]amino]carbonyl]-
- 2-(2-((4-(2-Chlorophenyl)thiazol-2-yl)carbamoyl)-1H-indol-1-yl)acetic acid
- 2-[2-[[4-(2-Chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]acetic acid hydrate
- 2-[[N-[4-(2-Chlorophenyl)-2-thiazolyl]amino]carbonyl]-1H-indole-1-acetic acid
- 2-[[[4-(2-Chlorophenyl)-2-thiazolyl]amino]carbonyl]-1H-indole-1-acetic acid
- Lintitript
- Sr 27897B
- Sr-27897
- [2-[4-(2-Chloro-phenyl)-thiazol-2-ylcarbamoyl]-indol-1-yl]-acetic acid
- See more synonyms
SR 27897 is a novel, non-peptide, orally active agent that selectively activates the receptor for substance P. Animal studies have shown that SR 27897 has a hypoglycemic effect and can reduce food intake. The drug binds to the receptor for substance P and inhibits the release of acetylcholine from nerve terminals in the bladder, which may be due to its ability to release melatonin from pineal gland cells. It is also thought that SR 27897 may have therapeutic potential in treating cancer.
Chemical properties
Technical inquiry about: 3D-LFA38185 SR 27897
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
